New York, N.Y. (April 8, 2010) Autism Speaks, the world's largest autism science and advocacy organization, today announced the awarding of 16 new research grants totaling $5,223,743 over the next three years. The new grants will span basic research, which provides the innovative discoveries that form the building blocks of medical breakthroughs, to translational neuroscience research, which further develops these discoveries in animal models, to treatment research, which tests the efficacy of new interventions in clinical populations, to dissemination research, which explores methods for promoting the use of validated treatments in the community.
"The Autism Speaks research portfolio is one of the significant ways in which we support individuals impacted with autism spectrum disorders (ASD) and their families," said Mark Roithmayr, president of Autism Speaks. "The research is immeasurable in its contribution to early and confident diagnosis, and to identifying effective treatments and therapies that are at the core of improving the lives of individuals with ASD," he continued. "Without the incredible generosity of our community and corporate partners, and the funds raised at hundreds of Walk Now for Autism Speaks events throughout the year, this research would not be possible."
Autism Speaks Chief Science Officer Geraldine Dawson, Ph.D. remarked, "By funding both basic science and applied research, we are making investments in studies with promise for immediate impact as well as in studies that will move the field in new directions for the future."
Novel directions in early detection of autism
Two studies to be funded are focused on developing new methods for very early detection of ASD. The first will validate a simple questionnaire that can be used by pediatricians to screen for ASD in one year-old babies (Using Parent Report to Identify Infants Who Are at Risk for Autism Spectrum Disorder (ASD) James Re
|Contact: Jane E. Rubinstein|